MedTrace Logo

Development and Evaluation of a Self-administered/Assisted Visual Field Screening Tool for Glaucoma

NCT02162043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2018-05-03

No results posted yet for this study

Summary

This project aims to evaluate a self-administered screening test for glaucoma, the second largest cause of blindness in the western world. New approaches to glaucoma screening are needed because a significant number of patients first present to hospitals with advanced-stage glaucoma and late presentation is associated with a much higher risk for future blindness. This project will develop a new user-friendly visual field test that will be made available through the internet for self-testing. It will conduct both hospital-based and community-based clinical trials to establish benefits and costs of this new test.

Conditions

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Principal Investigators

  • Prof David B Henson · University of Manchester

  • Emmanouil Tsamis · University of Manchester

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-10-01
Completion
2017-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162043 on ClinicalTrials.gov